Article Details

EHA 2024: Roche's Columvi competes in BiTE battle with positive results in DLBCL

Retrieved on: 2024-06-17 01:25:50

Tags for this article:

Click the tags to see associated articles and topics

EHA 2024: Roche's Columvi competes in BiTE battle with positive results in DLBCL. View article details on hiswai:

Excerpt

The trial evaluated Roche's Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (Glofit-GemOx) against GemOx with Roche's ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo